Scientific Sessions 2025  /  Featured Science in EP  /  Discussant
Logo

American Heart Association

  42
  0

Final ID:

Discussant

  • Olgin, Jeffrey  ( UCSF , Larkspur , California , United States )
  • Kutyifa, Valentina  ( UNIVERSITY OF ROCHESTER , Rochester , New York , United States )
  • Exner, Derek  ( University of Calgary , Calgary , Alberta , Canada )
  • Epstein, Andrew  ( UNIV PENNSYLVANIA , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Jeffrey Olgin: DO have relevant financial relationships ; Consultant:VivaLNK:Active (exists now) | Valentina Kutyifa: DO have relevant financial relationships ; Research Funding (PI or named investigator):Biotronik:Active (exists now) ; Research Funding (PI or named investigator):Spire Inc.:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Speaker:Medtronic:Past (completed) ; Speaker:Abbott Medical:Past (completed) ; Speaker:Boston Scientific:Past (completed) ; Consultant:ZOLL:Active (exists now) ; Research Funding (PI or named investigator):ZOLL:Past (completed) ; Research Funding (PI or named investigator):Boston Scientific:Past (completed) | Derek Exner: DO have relevant financial relationships ; Consultant:Abbott :Active (exists now) ; Ownership Interest:eMurmur :Active (exists now) ; Ownership Interest:ProtonIntel:Active (exists now) ; Ownership Interest:Clarius:Active (exists now) ; Consultant:GE Healthcare :Past (completed) ; Ownership Interest:CorVista :Active (exists now) ; Executive Role:HelpWear:Active (exists now) ; Consultant:Boston :Past (completed) ; Consultant:Medtronic :Past (completed) | Andrew Epstein: DO have relevant financial relationships ; Consultant:Abbott:Past (completed) ; Speaker:University of Pennsylvania:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Speaker:Mediasphere:Past (completed) ; Advisor:AHA:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Featured Science in EP

Monday, 11/10/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Efficacy and safety of flecainide compared to amiodarone for atrial fibrillation cardioversion in patients with Coronary Artery Disease and preserved ejection fraction. FLECA-ED trial

Tsioufis Panagiotis-anastasios, Patsilinakos Sotirios, Kafkas Nikos, Tsioufis Konstantinos, Tsiachris Dimitris, Argyriou Nikolaos, Botis Michail, Kordalis Athanasios, Doundoulakis Ioannis, Antoniou Christos-konstantinos, Matthaiopoulos George, Zamanis Ioannis

Primary Results from the Post Approval Study of a Next Generation Wearable Cardioverter Defibrillator System: the ACE-PAS Trial

Poole Jeanne, Gleva Marye, Branch Kelley, Birgersdotter-green Ulrika, Doshi Rahul, Mahankali Sridhar Arun Raghav, Wang Melinda, Gustavson Laura, Zulueta Shirley

More abstracts from these authors:
Can Leadless Pacemaker Expand the Role of Subcutaneous ICD?

Lloyd Michael, Pellegrini Cara, Exner Derek

Preliminary Results from the LiLAC Study: Living Life After Cardiogenic Shock Assessing Long-Term Quality of Life Outcomes Using Novel Digital Remote Monitoring Tools

Bell Fletcher, Marogi Emily, Hernandez-pastrana Sarai, Olgin Jeffrey, O'brien Connor

You have to be authorized to contact abstract author. Please, Login
Not Available